From: Limited cross-border infections in patients newly diagnosed with HIV in Europe
Characteristics | Categories | Total patients |
---|---|---|
Patients | 4260 | |
Continent of Origin, no. (%) | Western Europe | 2361 (55.4) |
Eastern Europe & Central Asia | 915 (21.5) | |
Sub-Saharan Africa | 467 (11.0) | |
Other | 517 (12.1) | |
Baseline values | HIV-RNA load, mean (IQR), log copies/ml | 4.8 (4.3-5.3) |
CD4 cell count, median (IQR), cells/mm3 | 354 (181–540) | |
Age, mean years (IQR) | 36.3 (29–42) | |
Gender, no. (%) | male | 3361 (78.9) |
Risk group, no. (%) | Men having Sex with Men (MSM) | 2061 (48.4) |
Heterosexual contact | 1477 (34.7) | |
Injection drug use | 347 (8.1) | |
Other | 39 (0.9) | |
unknown | 336 (7.9) | |
CDC stage, no. (%) | A and B | 3537 (83.0) |
C | 516 (12.1) | |
Subtype, no. (%) | B | 2820 (66.2) |
A | 477 (11.2) | |
C | 291 (6.8) | |
02_AG | 197 (4.6) | |
G | 137 (3.2) | |
F | 92 (2.2) | |
others | 167 (3.9) | |
unassigned | 79 (1.9) | |
non-B | 1361 (31.9) | |
Duration of infection, no. (%) | <1 year | 1228 (28.8) |
1-2 years | 141 (3.3) | |
Unknown duration | 2891 (67.9) | |
TDRM, no. (%) | present | 380 (8.9) |